Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay for the determination of sanfetrinem in human plasma

J Chromatogr B Biomed Sci Appl. 2001 Oct 25;762(2):193-201. doi: 10.1016/s0378-4347(01)00362-0.

Abstract

A rapid, selective and accurate high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of sanfetrinem in human plasma has been developed and validated. The performance of manual and automated sample preparation was assessed; 50 microl of plasma sample was deproteinized with acetonitrile, followed by dilution with water and injection onto the LC system. Chromatographic separation was achieved on a Phenomenex Luna C18(2), 50x2.0 (5 microm) column with a mobile phase consisting of water-acetonitrile with 0.1% formic acid followed by detection with a Perkin-Elmer API3000 mass spectrometer in multiple reaction monitoring mode. The lower limit of quantification was improved by five times compared to the UV method previously reported. A range of concentration from 10 ng/ml to 5 microg/ml was covered. The method was applied to the quantification of sanfetrinem in human plasma samples from healthy volunteers participating in a clinical study.

Publication types

  • Comparative Study
  • Validation Study

MeSH terms

  • Anti-Bacterial Agents / blood*
  • Anti-Infective Agents / blood*
  • Chromatography, High Pressure Liquid / methods*
  • Humans
  • Lactams*
  • Mass Spectrometry / methods*
  • Sensitivity and Specificity

Substances

  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Lactams
  • sanfetrinem